Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Preventive Medicine Physicians and the Centers for Disease Control and Prevention's 6|18 Initiative.

Livingston CJ, Allison RD, Niebuhr DW, Sherin KM, Costales VC, Berenji M, Phares TM, Caplan LS, Nelkovski L, Seeff LC, Singleton CM.

Am J Prev Med. 2019 Jul;57(1):127-133. doi: 10.1016/j.amepre.2019.02.014. Epub 2019 May 24. No abstract available.

PMID:
31130464
2.

CDC's 6|18 Initiative: A Cross-Sector Approach to Translating Evidence Into Practice.

Seeff LC, McGinnis T, Heishman H.

J Public Health Manag Pract. 2018 Sep/Oct;24(5):424-431. doi: 10.1097/PHH.0000000000000782.

PMID:
29474211
3.

Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening.

Goede SL, Kuntz KM, van Ballegooijen M, Knudsen AB, Lansdorp-Vogelaar I, Tangka FK, Howard DH, Chin J, Zauber AG, Seeff LC.

Med Care. 2015 Jul;53(7):630-8. doi: 10.1097/MLR.0000000000000380.

4.

Colorectal cancer incidence and screening - United States, 2008 and 2010.

Steele CB, Rim SH, Joseph DA, King JB, Seeff LC; Centers for Disease Control and Prevention (CDC).

MMWR Suppl. 2013 Nov 22;62(3):53-60.

PMID:
24264490
5.

Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts.

Seeff LC, DeGroff A, Joseph DA, Royalty J, Tangka FK, Nadel MR, Plescia M.

Cancer. 2013 Aug 1;119 Suppl 15:2940-6. doi: 10.1002/cncr.28155.

6.

Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs.

Tangka FK, Subramanian S, Beebe MC, Hoover S, Royalty J, Seeff LC.

Cancer. 2013 Aug 1;119 Suppl 15:2863-9. doi: 10.1002/cncr.28154.

7.

Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program.

Subramanian S, Tangka FK, Hoover S, Beebe MC, DeGroff A, Royalty J, Seeff LC.

Cancer. 2013 Aug 1;119 Suppl 15:2855-62. doi: 10.1002/cncr.28158.

8.

Outpatient colonoscopy complications in the CDC's Colorectal Cancer Screening Demonstration Program: a prospective analysis.

Castro G, Azrak MF, Seeff LC, Royalty J.

Cancer. 2013 Aug 1;119 Suppl 15:2849-54. doi: 10.1002/cncr.28159.

9.

Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program.

Nadel MR, Royalty J, Shapiro JA, Joseph D, Seeff LC, Lane DS, Dwyer DM.

Cancer. 2013 Aug 1;119 Suppl 15:2834-41. doi: 10.1002/cncr.28164.

10.

Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.

Seeff LC, Royalty J, Helsel WE, Kammerer WG, Boehm JE, Dwyer DM, Howe WR Jr, Joseph D, Lane DS, Laughlin M, Leypoldt M, Marroulis SC, Mattingly CA, Nadel MR, Phillips-Angeles E, Rockwell TJ, Ryerson AB, Tangka FK.

Cancer. 2013 Aug 1;119 Suppl 15:2820-33. doi: 10.1002/cncr.28163.

11.

Lessons learned from the CDC's Colorectal Cancer Screening Demonstration Program.

Seeff LC, Rohan EA.

Cancer. 2013 Aug 1;119 Suppl 15:2817-9. doi: 10.1002/cncr.28165.

12.

Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey.

Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A.

Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):895-904. doi: 10.1158/1055-9965.EPI-12-0192. Epub 2012 Apr 6.

13.

Colorectal cancer screening - United States, 2002, 2004, 2006, and 2008.

Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC; Centers for Disease Control and Prevention (CDC).

MMWR Suppl. 2011 Jan 14;60(1):42-6. No abstract available.

PMID:
21430619
14.

Comprehensive cancer control programs and coalitions: partnering to launch successful colorectal cancer screening initiatives.

Seeff LC, Major A, Townsend JS, Provost E, Redwood D, Espey D, Dwyer D, Villanueva R, Larsen L, Rowley K, Leonard B.

Cancer Causes Control. 2010 Dec;21(12):2023-31. doi: 10.1007/s10552-010-9664-9. Epub 2010 Nov 18. Review.

PMID:
21086035
15.

Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of five programs.

Subramanian S, Tangka FK, Hoover S, Degroff A, Royalty J, Seeff LC.

Eval Program Plann. 2011 May;34(2):147-53. doi: 10.1016/j.evalprogplan.2010.09.005. Epub 2010 Oct 30.

PMID:
21036399
16.

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.

Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede SL, Ries LA.

Cancer. 2010 Feb 1;116(3):544-73. doi: 10.1002/cncr.24760.

17.

Serious complications within 30 days of screening and surveillance colonoscopy are uncommon.

Ko CW, Riffle S, Michaels L, Morris C, Holub J, Shapiro JA, Ciol MA, Kimmey MB, Seeff LC, Lieberman D.

Clin Gastroenterol Hepatol. 2010 Feb;8(2):166-73. doi: 10.1016/j.cgh.2009.10.007. Epub 2009 Oct 20. Erratum in: Clin Gastroenterol Hepatol. 2010 Dec;8(12):1100.

18.

The impact of detection and treatment on lifetime medical costs for patients with precancerous polyps and colorectal cancer.

Howard DH, Tangka FK, Seeff LC, Richardson LC, Ekwueme DU.

Health Econ. 2009 Dec;18(12):1381-93. doi: 10.1002/hec.1434.

PMID:
19142856
19.

Increase in screening for colorectal cancer in older Americans: results from a national survey.

Chen X, White MC, Peipins LA, Seeff LC.

J Am Geriatr Soc. 2008 Aug;56(8):1511-6. doi: 10.1111/j.1532-5415.2008.01796.x. Epub 2008 Jul 24.

PMID:
18662217
20.

Colorectal cancer test use from the 2005 National Health Interview Survey.

Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1623-30. doi: 10.1158/1055-9965.EPI-07-2838.

21.

Development of a federally funded demonstration colorectal cancer screening program.

Seeff LC, DeGroff A, Tangka F, Wanliss E, Major A, Nadel M, Ryerson AB, Royalty J, Gelb C, Reed E.

Prev Chronic Dis. 2008 Apr;5(2):A64. Epub 2008 Mar 15.

22.

Cost of starting colorectal cancer screening programs: results from five federally funded demonstration programs.

Tangka FK, Subramanian S, Bapat B, Seeff LC, DeGroff A, Gardner J, Ryerson AB, Nadel M, Royalty J.

Prev Chronic Dis. 2008 Apr;5(2):A47. Epub 2008 Mar 15.

23.

Facilitators and challenges to start-up of the colorectal cancer screening demonstration program.

DeGroff A, Boehm J, Goode Green S, Holden D, Seeff LC.

Prev Chronic Dis. 2008 Apr;5(2):A39. Epub 2008 Mar 15.

24.

Start-up of the colorectal cancer screening demonstration program.

DeGroff A, Holden D, Goode Green S, Boehm J, Seeff LC, Tangka F.

Prev Chronic Dis. 2008 Apr;5(2):A38. Epub 2008 Mar 15.

25.

Complications of colonoscopy in an integrated health care delivery system.

Levin TR, Zhao W, Conell C, Seeff LC, Manninen DL, Shapiro JA, Schulman J.

Ann Intern Med. 2006 Dec 19;145(12):880-6.

PMID:
17179057
26.

Use of the spatial scan statistic to identify geographic variations in late stage colorectal cancer in California (United States).

Pollack LA, Gotway CA, Bates JH, Parikh-Patel A, Richards TB, Seeff LC, Hodges H, Kassim S.

Cancer Causes Control. 2006 May;17(4):449-57.

PMID:
16596297
27.

Colorectal cancer test use among Hispanic and non-Hispanic U.S. populations.

Pollack LA, Blackman DK, Wilson KM, Seeff LC, Nadel MR.

Prev Chronic Dis. 2006 Apr;3(2):A50. Epub 2006 Mar 15.

28.

Can we predict the outcomes of national colorectal cancer screening and can predictions help us plan?

Seeff LC, Tangka FK.

Gastroenterology. 2005 Oct;129(4):1339-42. No abstract available.

PMID:
16230085
29.

Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults.

Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML.

Med Care. 2005 Sep;43(9):939-44.

PMID:
16116360
30.

Market for colorectal cancer screening by endoscopy in the United States.

Tangka FK, Molinari NA, Chattopadhyay SK, Seeff LC.

Am J Prev Med. 2005 Jul;29(1):54-60.

PMID:
15958253
31.

Does health insurance coverage of office visits influence colorectal cancer testing?

Varghese RK, Friedman C, Ahmed F, Franks AL, Manning M, Seeff LC.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):744-7.

32.

A national survey of primary care physicians' methods for screening for fecal occult blood.

Nadel MR, Shapiro JA, Klabunde CN, Seeff LC, Uhler R, Smith RA, Ransohoff DF.

Ann Intern Med. 2005 Jan 18;142(2):86-94.

PMID:
15657156
33.

How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity.

Seeff LC, Richards TB, Shapiro JA, Nadel MR, Manninen DL, Given LS, Dong FB, Winges LD, McKenna MT.

Gastroenterology. 2004 Dec;127(6):1670-7.

PMID:
15578503
34.

Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?

Seeff LC, Manninen DL, Dong FB, Chattopadhyay SK, Nadel MR, Tangka FK, Molinari NA.

Gastroenterology. 2004 Dec;127(6):1661-9.

PMID:
15578502
35.

Patterns and predictors of colorectal cancer test use in the adult U.S. population.

Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ.

Cancer. 2004 May 15;100(10):2093-103.

36.

Cervical cancer mortality among foreign-born women living in the United States, 1985 to 1996.

Seeff LC, McKenna MT.

Cancer Detect Prev. 2003;27(3):203-8.

PMID:
12787727
37.
38.

Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey.

Nadel MR, Blackman DK, Shapiro JA, Seeff LC.

Prev Med. 2002 Sep;35(3):199-206.

PMID:
12202061
39.

Colorectal cancer-screening tests and associated health behaviors.

Shapiro JA, Seeff LC, Nadel MR.

Am J Prev Med. 2001 Aug;21(2):132-7.

PMID:
11457633
40.

Observations from the CDC: CDC's Screen for Life: a National Colorectal Cancer Action Campaign.

Jorgensen CM, Gelb CA, Merritt TL, Seeff LC.

J Womens Health Gend Based Med. 2001 Jun;10(5):417-22.

PMID:
11445039

Supplemental Content

Loading ...
Support Center